Skip to main content
TipRanks
Go Ultimate75% OFF

VITA 34 (0NLV) Share Price & Analysis

0 Followers

0NLV Stock Chart & Stats

€2.46€0.15(6.49%)
At close: 4:30 PM GMT
€2.4€2.6€2.8Aug 24Oct 19Nov 4Nov 16
Day’s Range
EUR 2.46 - EUR 2.46
52-Week Range
EUR 2.31 - EUR 7.00
Previous Close
EUR 2.31
Volume
N/A
Average Volume (3M)
2
Market Cap
EUR 42.71M
Enterprise Value
EUR 73.56M
Total Cash (Recent Filing)
EUR 12.45M
Total Debt (Recent Filing)
EUR 23.03M
Price to Earnings (P/E)
―
Beta
0.37
Next Earnings
Nov 30, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Sustained revenue expansion indicates improving demand for VITA 34’s biological-material collection and storage services. Continued top-line growth can improve operating leverage, support investment in the platform, and strengthen the company’s ability to absorb fixed costs over the next several quarters.

Improving Profitability

The recovery in gross margin and the return to positive EBITDA show meaningful improvement in the underlying operating model. If maintained, stronger margins should increase cash conversion potential, provide greater flexibility for growth investment, and move the company closer to sustainable profitability.

Positive Cash Generation

Positive operating and free cash flow provide an important source of internal funding despite the reported net loss. This supports ongoing operations and reduces immediate reliance on external capital, although the benefit will be more durable if the recent improvement proves consistent.

Bears Say

Persistent Losses

VITA 34 has not yet converted its improving revenue and margins into positive bottom-line earnings. Continued net losses can consume the company’s limited equity cushion, restrict reinvestment capacity, and make financial performance more dependent on further operational improvement.

Elevated Leverage

The sharp increase in leverage and thin equity base materially reduce financial flexibility. A smaller capital cushion leaves less capacity to absorb weaker results, fund expansion internally, or manage obligations without additional financing, making balance-sheet risk a durable constraint on the business.

Cash-flow Inconsistency

Although current cash generation is positive, the historical volatility and sharply negative latest free-cash-flow growth indicate that the improvement may not yet represent a stable run rate. Inconsistent conversion of earnings and operations into cash could complicate debt management and investment planning.

0NLV FAQ

What was VITA 34’s price range in the past 12 months?
VITA 34 lowest share price was €2.31 and its highest was €7.00 in the past 12 months.
What is VITA 34’s market cap?
VITA 34’s market cap is €42.71M.
When is VITA 34’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VITA 34’s earnings last quarter?
VITA 34 released its earnings results on Aug 28, 2026. The company reported -€0.063 earnings per share for the quarter.
Is VITA 34 overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does VITA 34 pay dividends?
VITA 34 does not currently pay dividends.
What is VITA 34’s EPS estimate?
VITA 34’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VITA 34 have?
VITA 34 has 17,640,104 shares outstanding.
What happened to VITA 34’s price movement after its last earnings report?
VITA 34 reported an EPS of -€0.063 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of VITA 34?
Currently, no hedge funds are holding shares in GB:0NLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology